Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56,047,431
-
Total 13F shares
-
37,124,609
-
Share change
-
+3,724,331
-
Total reported value
-
$405,366,758
-
Put/Call ratio
-
12%
-
Price per share
-
$10.95
-
Number of holders
-
87
-
Value change
-
+$42,350,563
-
Number of buys
-
52
-
Number of sells
-
35
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q2 2014
As of 30 Jun 2014 SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) had 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 37,124,609 shares of stock of the company.
Largest 10 holders included NEA Management Company, LLC, Abingworth LLP, PRICE T ROWE ASSOCIATES INC /MD/, Murphy Michael R, ARDSLEY ADVISORY PARTNERS, Ameriprise Financial Inc, Consonance Capital Management LP, Orchard Hill Capital Management LP, BlackRock Fund Advisors, and NORTHPOINTE CAPITAL LLC.
This table shows 87 institutional shareholders of the security as of 30 Jun 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.